To do this we tested the hypotheses that amisulpride interacts with GLUT1 at the BBB, and that the expression of BBB transporters and the transport of amisulpride and glucose into the brain will be affected by AD. The gene discussed is SLC2A1; the disease is Alzheimer disease.